When NAD+ is depleted, ATP production suffers and fatigue results
If human trials with the compound show safety and efficacy, NNMT inhibitors like 5-amino-1MQ could serve to prevent and/or slow age-related muscle deterioration in humans, a tantalizing prospect
Its deficiency can lead to a specific type of anemia called megaloblastic anemia, characterized by the production of abnormally large and dysfunctional red blood cells
By blocking NNMT, 5-Amino-1MQ prevents NAD+ breakdown , allowing its levels to rise
As mitochondrial function drops with age, your metabolism slows down
Any therapeutic use occurs under physician supervision as off-label research application requiring comprehensive informed consent, medical monitoring, and understanding that the peptide is not an approved pharmaceutical agent